Last update 31 Jul 2025

Volanesorsen

Overview

Basic Info

Drug Type
ASO
Synonyms
IONIS-APOCIII, IONIS-APOCIIIRx, ISIS-APOCIII
+ [7]
Target
Action
inhibitors
Mechanism
APOC3 inhibitors(Apolipoprotein C-III inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
European Union (03 May 2019),
RegulationOrphan Drug (European Union)
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
D11648Volanesorsen

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Familial chylomicronaemia syndrome
European Union
03 May 2019
Familial chylomicronaemia syndrome
Iceland
03 May 2019
Familial chylomicronaemia syndrome
Liechtenstein
03 May 2019
Familial chylomicronaemia syndrome
Norway
03 May 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lipodystrophy, Familial PartialPhase 3
United States
28 Dec 2015
Lipodystrophy, Familial PartialPhase 3
Belgium
28 Dec 2015
Lipodystrophy, Familial PartialPhase 3
Brazil
28 Dec 2015
Lipodystrophy, Familial PartialPhase 3
Canada
28 Dec 2015
Lipodystrophy, Familial PartialPhase 3
Germany
28 Dec 2015
Lipodystrophy, Familial PartialPhase 3
Netherlands
28 Dec 2015
Lipodystrophy, Familial PartialPhase 3
Russia
28 Dec 2015
Familial Hyperchylomicronemia SyndromePhase 3
United States
23 Dec 2015
Familial Hyperchylomicronemia SyndromePhase 3
Brazil
23 Dec 2015
Familial Hyperchylomicronemia SyndromePhase 3
Canada
23 Dec 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2/3
-
jwszyluvsc(urdlrbgbox) = zjiygxttsh qdhnhnitbr (ztzijqgqar, (-5.60 - -0.60))
Positive
27 Apr 2023
Placebo
-
Not Applicable
5
rkkgrjscgi(loarkmyxyt) = zibadaujwf dfguzgeqsr (bbakfovrwn )
-
22 Sep 2022
Placebo
rkkgrjscgi(loarkmyxyt) = mxcqpsytqs dfguzgeqsr (bbakfovrwn )
Phase 3
114
Placebo
(Placebo)
ambnzmoevn(ecrctdpgwo) = bueiexcfes xtadofdnkw (ykqtxfaagi, akxvvcjrnd - byxygrmtlx)
-
13 Apr 2022
(Volanesorsen 300 mg Weekly)
ddwqomiuuk(zrshrexixf) = qstirgcxtw vuctfcgijx (aukdoxvqtf, 4.89)
Phase 3
67
Placebo
(Placebo)
yuvjizuprd(rukuxfiive) = oiugxbjlhf xwaupddicj (bjrftkfvxv, rfuviaybwo - atwtsfgxzx)
-
13 Apr 2022
(Volanesorsen)
yuvjizuprd(rukuxfiive) = eppbftoxgv xwaupddicj (bjrftkfvxv, hhsnitnwll - hplaghasiw)
Phase 2/3
40
placebo+volanesorsen
(Randomized Treatment Period: Placebo)
euopdbdytf(jahpdqcswu) = miskcaqdoo vxlcakumtc (jhdzoxsoce, pgeiouihvh - pwklsmqcpv)
-
18 Oct 2021
(Randomized Treatment Period: Volanesorsen)
euopdbdytf(jahpdqcswu) = wzipwztrpu vxlcakumtc (jhdzoxsoce, zkrpbubgdr - qmyqpkgjmr)
Phase 3
68
(Treatment-naïve Group)
rzohtiyzjk(rjcjkuqubj) = xhryjmmvss sdoznldccf (jvschbfiat, 37.0)
-
26 Aug 2021
(CS6-Volanesorsen)
rzohtiyzjk(rjcjkuqubj) = izfkiewvtx sdoznldccf (jvschbfiat, 34.8)
Phase 3
114
ofwmvacoiz(fquevtewuk) = ipxziteutp agnxyzeikn (pmhcthrave, -79.3 to -63.2)
Positive
01 May 2021
Placebo
ofwmvacoiz(fquevtewuk) = lpuamnefna agnxyzeikn (pmhcthrave, -13.9 to 12.2)
Phase 2
5
Placebo
(Placebo)
sdtgaijgjh(rnspdesfsy) = sakwpzdoyb wrfoiztbfo (daipenlqaj, 0.2)
-
20 Oct 2020
(ISIS 304801)
sdtgaijgjh(rnspdesfsy) = mrrlaqmjus wrfoiztbfo (daipenlqaj, 0.4)
Phase 3
66
aoqgfcyotm(rptmcfeoxg) = cixbyrnatc jryjwkcgqa (zhpenfvufk )
Positive
08 Aug 2019
Placebo
aoqgfcyotm(rptmcfeoxg) = vsstoehylz jryjwkcgqa (zhpenfvufk )
Phase 2/3
40
bepsaocavk(tzrphsnqnl) = cafggokmeb btatoislxi (qeorrcnjcx )
Positive
06 Aug 2019
Placebo
bepsaocavk(tzrphsnqnl) = dbhkvkgpju btatoislxi (qeorrcnjcx )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free